Anthony Fauci: US could reach 100,000 new coronavirus cases a day

By: |
July 1, 2020 10:22 AM

Asked to forecast the outcome of recent surges in some states, Fauci said he can't make an accurate prediction but believes it will be "very disturbing".

Anthony Fauci, coronavirus cases in US, COVID-19 cases,  covid 19 death cases in US, latest news on coronavirus outbrteakFauci said areas seeing recent outbreaks are putting the entire nation at risk, including areas that have made progress in reducing COVID-19 cases.

Top US infectious disease expert Dr Anthony Fauci has said coronavirus cases could grow to 100,000 a day in the country if Americans don’t start following public health recommendations. He made the remark on Tuesday at a Senate hearing on reopening schools and workplaces.

Asked to forecast the outcome of recent surges in some states, Fauci said he can’t make an accurate prediction but believes it will be “very disturbing”.

“We are now having 40-plus-thousand new cases a day. I would not be surprised if we go up to to 100,000 a day if this does not turn around, and so I am very concerned,” said Fauci, infectious disease chief at the National Institutes of Health.

Also read| Check Coronavirus latest updates here:

Fauci said areas seeing recent outbreaks are putting the entire nation at risk, including areas that have made progress in reducing COVID-19 cases. He cited recent video footage of people socialising in crowds, often without masks, and otherwise ignoring safety guidelines.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Palaniswami assures free COVID-19 vaccine to TN people
2COVID vaccine will be distributed under special immunization programme: Officials
3IAVI, Merck KGaA, Serum Institute join hands to develop monoclonal antibodies for COVID-19